Pharmaceutical

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.

Aug 22, 2023 - 20:00
AI drug discovery company Genesis Therapeutics wins $200m in Series B round
The company’s generative and predictive AI-powered drug discovery platform is already being used by Eli Lilly.
Read the original article

Tags:

Previous Article

Leo Pharma to acquire US company Timber Pharmaceuticals

Next Article

Roche And Exelixis’ Drug Combo Grabs Late-Stage Prostate Cancer Victory

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: STAT+: An overlooked way to make participants in clinical trials look more like America

Opinion: STAT+: An overlooked way to make participants ...

May 27, 2023

XtalPi’s AI biologics discovery platform licensed to Janssen Biotech

XtalPi’s AI biologics discovery platform licensed to Ja...

Oct 12, 2024

With latest tranche, U.K. Biobank has genome sequences from 500,000 people available for research

With latest tranche, U.K. Biobank has genome sequences ...

Nov 29, 2023